Retrograde signaling in the regulation of synaptic transmission: Focus on endocannabinoids

Progress in Neurobiology

Volumn 68, Issue 4, 2002, Pages 247-286

  Alger, Bradley E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID RECEPTOR; ADENOSINE; ANANDAMIDE; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CALCIUM CHANNEL; CALCIUM ION; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CARBON MONOXIDE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DYNORPHIN; GLUTAMIC ACID; GROWTH FACTOR; LIPID; METABOTROPIC RECEPTOR; MUSCARINIC RECEPTOR; NEUROPEPTIDE; NEUROTRANSMITTER; NITRIC OXIDE; OPIATE PEPTIDE; OXYTOCIN; POTASSIUM CHANNEL; POTASSIUM ION; QUINPIROLE; RECEPTOR; RIMONABANT; SECRETIN; VASOPRESSIN;

BEHAVIOR; CALCIUM TRANSPORT; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CORPUS STRIATUM; DEPOLARIZATION; DRUG ACTIVITY; ELECTRIC POTENTIAL; EXCITATION; HIPPOCAMPUS; KINETICS; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROPHYSIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; POSTSYNAPTIC MEMBRANE; PREFRONTAL CORTEX; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SYNAPTIC TRANSMISSION; SYNAPTOSOME;

ANIMALS; CENTRAL NERVOUS SYSTEM; CEREBELLUM; ENDOCANNABINOIDS; FATTY ACIDS, UNSATURATED; HIPPOCAMPUS; HOMEOSTASIS; HUMANS; MAMMALS; MEMBRANE POTENTIALS; NERVE GROWTH FACTOR; NEURAL INHIBITION; NEURONAL PLASTICITY; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; PRESYNAPTIC TERMINALS; RECEPTORS, PRESYNAPTIC; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 0036867665     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(02)00080-1     Document Type: Review

References (268)

1. Alagarsamy S., Sorensen S.D., Conn P.J. Coordinate regulation of metabotropic glutamate receptors. Curr. Opin. Neurobiol. 11:2001;357-362.
2. A receptor synapses in the mammalian CNS. Trends Neurosci. 18:1995;333-340.
3. Alger B.E., Pitler T.A., Wagner J.J., Martin L.A., Morishita W., Kirov S.A., Lenz R.A. Retrograde signalling in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. J. Physiol. (London). 496:1996;197-209.
4. Al-Hayani A., Davies S.N. Cannabinoid receptor-mediated inhibition of excitatory synaptic transmission in the rat hippocampal slice is developmentally regulated. Br. J. Pharmacol. 131:2000;663-665.
5. Ameri A. The effects of cannabinoids on the brain. Prog. Neurobiol. 58:1999;315-348.
6. Ameri A., Simmet T. Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 361:2000;265-272.
7. Auclair N., Otani S., Soubrie P., Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J. Neurophysiol. 83:2000;3287-3293.
8. Baranano D.E., Snyder S.H. Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 98:2001;10996-11002.
9. Baranano D.E., Ferris C.D., Snyder S.H. Atypical neural messengers. Trends Neurosci. 24:2001;99-106.
10. Barker J.L., Crayton J.W., Nicoll R.A. Noradrenaline and acetylcholine responses of supraoptic neurosensory cells. J. Physiol. 218:1971;19-32.
11. Bazan N.G. Arachidonic acid in the modulation of excitable membrane function and at the onset of brain damage. Ann. N. Y. Acad. Sci. 559:1989;1-16.
12. Bazan N.G. The neuromessenger platelet-activating factor in plasticity and neurodegeneration. Prog. Brain Res. 118:1998;281-291.
13. Bear M.F., Abraham W.C. Long-term depression in hippocampus. Ann. Rev. Neurosci. 19:1996;437-462.
14. Bazan N.G., Allan G. Platelet-activating factor in the modulation of excitatory amino acid neurotransmitter release and of gene expression. J. Lipid Mediat. Cell Signal. 14:1996;321-330.
15. Beinfeld M.C., Connolly K. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Neurosci. Lett. 301:2001;69-71.
16. Bohme G.A., La Ville M., Ledent C., Parmentier M., Imperato A. Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience. 95:2000;5-7.
17. Bortolotto Z.A., Fitzjohn S.M., Collingridge G.L. Roles of metabotropic glutamate receptors in LTP and LTD in the hippocampus. Curr. Opin. Neurobiol. 9:1999;299-304.
18. Brundege J.M., Dunwiddie T.V. Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. J. Neurosci. 16:1996;5603-5612.
19. Calabresi P., Pisani A., Mercuri N.B., Bernardi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci. 19:1996;19-24.
20. Carlson G., Wang Y., Alger B.E. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci. 5:2002;723-724.
21. Casado M., Isope P., Ascher P. Involvement of presynaptic N-methyl-D-aspartate receptors in cerebellar long-term depression. Neuron. 33:2002;123-130.
22. Caulfield M.P., Brown D.A. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a Pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 106:1992;231-232.
23. Caulfield M.P., Robbins J., Brown D.A. Neurotransmitters inhibit the omega-conotoxin-sensitive component of Ca current in neuroblastoma × glioma hybrid (NG108-15) cells, not the nifedipine-sensitive component. Pflugers Arch. 420:1992;486-492.
24. 2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum. J. Neurosci. 21:2001;7841-7847.
25. Chen W.R., Xiong W., Shepherd G.M. Analysis of relations between NMDA receptors and GABA release at olfactory bulb reciprocal synapses. Neuron. 25:2000;625-633.
26. Cheramy A., Leviel V., Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature. 289:1981;537-542.
27. Choi S., Lovinger D.M. Decreased frequency but not amplitude of quantal synaptic responses associated with expression of corticostriatal long-term depression. J. Neurosci. 17:1997;8613-8620.
28. Cobb W.S., Abercrombie E.D. Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol. J. Neurosci. 22:2002;1407-1413.
29. Cochilla A.J., Alford S. Metabotropic glutamate receptor-mediated control of neurotransmitter release. Neuron. 20:1998;1007-1016.
30. + channels. Ann. N. Y. Acad. Sci. 868:1999;233-285.
31. Conn P.J., Pin J.-P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37:1997;205-237.
32. Crepel F., Daniel H., Hemart N., Jaillard D. Effects of ACPD and AP3 on parallel-fibre-mediated EPSPs of Purkinje cells in cerebellar slices in vitro. Exp. Brain Res. 86:1991;402-406.
33. Daniel H., Levenes C., Crepel F. Cellular mechanisms of cerebellar LTD. Trends Neurosci. 21:1998;401-407.
34. Deadwyler S.A., Hampson R.E., Bennett B.A., Edwards T.A., Mu J., Pacheco M.A., Ward S.J., Childers S.R. Cannabinoids modulate potassium currents in cultured hippocampal neurons. Receptors Channels. 1:1993;121-134.
35. Deadwyler S.A., Hampson R.E., Mu J., Whyte A., Childers S. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther. 273:1995;734-743.
36. Desai M.A., McBain C.J., Kauer J.A., Conn P.J. Metabotropic glutamate receptor-induced disinhibition is mediated by reduced transmission at excitatory synapses onto interneurons and inhibitory synapses onto pyramidal cells. Neurosci. Lett. 181:1994;78-82.
37. Diana M.A., Levenes C., Mackie K., Marty A. Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. J. Neurosci. 22:2002;200-208.
38. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.-C., Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:1994;686-691.
39. Di Marzo V., Melck D., Bisogno T., De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21:1998;521-528.
40. Di Marzo V., Goparaju S., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter P., Sugiura T., Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature. 410:2001;822-825.
41. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U.S.A. 99:2002;10819-10824.
42. Drake C.T., Terman G.W., Simmons M.L., Milner T.A., Kunkel D.D., Schwartzkroin P.A., Chavkin C. Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters. J. Neurosci. 14:1994;3736-3750.
43. Dunwiddie T.V., Haas H.L. Adenosine increases synaptic facilitation in the in vitro rat hippocampus: evidence for a presynaptic site of action. J. Physiol. (London). 369:1985;365-377.
44. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Ann. Rev. Neurosci. 24:2001;31-55.
45. Egertova M., Elphick M.R. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB1. J. Comp. Neurol. 422:2000;159-171.
46. Falkenburger B.H., Barstow K.L., Mintz I.M. Dendrodendritic inhibition through reversal of dopamine transport. Science. 293:2001;2465-2470.
47. Fawcett J.P., Aloyz R., McLean J.H., Pareek S., Miller F.D., McPherson P.S., Murphy R.A. Detection of brain-derived neurotrophic factor in a vesicular fraction of brain synaptosomes. J. Biol. Chem. 272:1997;8837-8840.
48. Fawcett J.P., Bamji S.X., Causing C.G., Aloyz R., Ase A.R., Reader T.A., McLean J.H., Miller F.D. Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS. J. Neurosci. 18:1998;280-282.
49. Fierro L., DiPolo R., Llano I. Intracellular calcium clearance in Purkinje cell somata from rat cerebellar slices. J. Physiol. (London). 510:1998;499-512.
50. Fitzsimonds R.M., Poo M. Retrograde signaling in the development and modification of synapses. Physiol. Rev. 78:1998;143-170.
51. Frerking M., Malenka R.C., Nicoll R.A. Brain-derived neurotrophic factor (BDNF) modulates inhibitory, but not excitatory, transmission in the CA1 region of the hippocampus. J. Neurophysiol. 80:1998;3383-3386.
52. Freund T.F., Buzsaki G. Interneurons of the hippocampus. Hippocampus. 6:1996;347-470.
53. Freund, T.F., Katona, I., Piomelli, D., 2002. The role of endogenous cannabinoids in synaptic signaling. Physiol. Rev., submitted for publication.
54. Frey U., Morris R.G.M. Synaptic tagging: implications for late maintenance of hippocampal long-term potentiation. Trends Neurosci. 21:1998;181-188.
55. 2+ channels. J. Neurosci. 18:1998;9163-9170.
56. Geffen L.B., Jessell T.M., Cuello A.C., Iversen L.L. Release of dopamine from dendrites in rat substantia nigra. Nature. 260:1976;258-260.
57. Gerdeman G., Lovinger D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol. 85:2001;468-471.
58. Gerdeman G.L., Ronesi J., Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5:2002;446-451.
59. Gereau R.W. IV, Conn P.J. Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1. J. Neurosci. 15:1995a;6879-6889.
60. Gereau R.W. IV, Conn P.J. Roles of specific metabotropic glutamate receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability. J. Neurophysiol. 74:1995b;122-129.
61. Giuffrida A., Parsons L.H., Kerr T.M., Rodriguez de Fonseca F., Navarro M., Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2:1999;358-363.
62. Giuffrida A., Beltramo M., Piomelli D. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J. Pharmacol. Exp. Ther. 298:2001;7-14.
63. Glitsch M.D., Jack J.J. Evidence that glutamate acting on presynaptic type-II metabotropic glutamate receptors alone does not fully account for the phenomenon of depolarisation-induced suppression of inhibition in cerebellar Purkinje cells. Pflugers Arch. 442:2001;404-408.
64. Glitsch M.D., Marty A. Presynaptic effects of NMDA in cerebellar Purkinje cells and interneurons. J. Neurosci. 19:1999;511-519.
65. Glitsch M.D., Llano I., Marty A. Glutamate as a candidate retrograde messenger at interneuron-Purkinje cell synapses of rat cerebellum. J. Physiol. (London). 497:1996;531-537.
66. 2+. Eur. J. Neurosci. 12:2000;987-993.
67. Grassi S., Pettorossi V.E. Synaptic plasticity in the medial vestibular nuclei: role of glutamate receptors and retrograde messengers in rat brainstem slices. Prog. Neurobiol. 64:2001;527-553.
68. Greene R.W., Haas H.L. The electrophysiology of adenosine in the mammalian central nervous system. Prog. Neurobiol. 36:1991;329-341.
69. Gross R.A., Moises H.C., Uhler M.D., Macdonald R.L. Dynorphin A and cAMP-dependent protein kinase independently regulate neuronal calcium currents. Proc. Natl. Acad. Sci. U.S.A. 87:1990;7025-7029.
70. Gubellini P., Saulle E., Centonze D., Bonsi P., Pisani A., Benardi G., Conquet F., Calabresi P. Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharmacology. 40:2001;839-846.
71. Hajos N., Katona I., Naiem S.S., Mackie K., Ledent C., Mody I., Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 12:2000;3239-3249.
72. Hajos N., Ledent C., Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience. 106:2001;1-4.
73. Halabisky B., Friedman D., Radojicic M., Strowbridge B.W. Calcium influx through NMDA receptors directly evokes GABA release in olfactory bulb granule cells. J. Neurosci. 20:2000;5124-5134.
74. Haley J.E. Gases as neurotransmitters. Essays Biochem. 33:1998;79-91.
75. Hansel C., Linden D.J., D'Angelo E. Beyond parallel fiber LTD: the diversity of synaptic and non-synaptic plasticity in the cerebellum. Nat. Neurosci. 4:2001;467-475.
76. Hanson J.E., Smith Y. Group I metabotropic glutamate receptors at GABAergic synapses in monkeys. J. Neurosci. 19:1999;6488-6496.
77. Hartmann M., Heumann R., Lessmann V. Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J. 20:2001;5887-5897.
78. Haul S., Godecke A., Schrader J., Haas H.L., Luhmann H.J. Impairment of neocortical long-term potentiation in mice deficient of endothelial nitric oxide synthase. J. Neurophysiol. 81:1999;494-497.
79. Hawkins R.D., Zhuo M., Arancio O. Nitric oxide and carbon monoxide as possible retrograde messengers in hippocampal long-term potentiation. J. Neurobiol. 25:1994;652-665.
80. 2+ signaling in dendrites of pyramidal neurons. Biophys. J. 70:1996;1069-1081.
81. Henry D.J., Chavkin C. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci. Lett. 186:1995;91-94.
82. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A. 87:1990;1932-1936.
83. 2+ channels by G-protein βγ-subunits. Nature. 380:1996;258-262.
84. Hirasawa M., Kombian S.B., Pittman Q.J. Oxytocin retrogradely inhibits evoked, but not miniature, EPSCs in the rat supraoptic nucleus: role of N- and P/Q-type calcium channels. J. Physiol. (London). 532:2001;595-607.
85. A synaptic transmission in the hippocampus. J. Neurosci. 20:2000;2470-2479.
86. Holscher C. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci. 20:1997;298-303.
87. Howlett A.C., Bidaut-Russell M., Devane W.A., Melvin L.S., Johnson M.R., Herkenham M. The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci. 13:1990;420-423.
88. Huang E.J., Reichardt L.F. Neurotrophins in neuronal development and function. Ann. Rev. Neurosci. 24:2001;677-736.
89. Huang C.-C., Lo S.-W., Hsu K.-S. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J. Physiol. (London). 532:2001;731-748.
90. Hubert G.W., Paquet M., Smith Y. Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey substantia nigra. J. Neurosci. 21:2001;1838-1847.
91. Ikeda S. Voltage-dependent modulation of N-type calcium channels by G-protein βγ-subunits. Nature. 380:1996;255-258.
92. 2+-permeable AMPA receptors in Bergmann glia. Science. 292:2001;926-929.
93. Irving A.J., Coutts A.A., Harvey J., Rae M.G., Mackie K., Bewick G.S., Pertwee R.G. Functional expression of cell surface cannabinoid CB1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons. Neuroscience. 98:2000;253-262.
94. Isaacson J.S., Solis J.M., Nicoll R.A. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron. 10:1993;165-175.
95. Ishikawa T., Sahara Y., Takahashi T. A single packet of transmitter does not saturate postsynaptic glutamate receptors. Neuron. 34:2002;613-621.
96. A IPSCs in the dentate granule cells of the hippocampus. Soc. Neurosci. Abstr. 27:2001;499.
97. 2+ accumulation in hippocampal pyramidal neurons based on fluorescence imaging measurements. J. Neurophysiol. 71:1994;1065-1077.
98. Jaffe E.H., Marty A., Schulte A., Chow R.H. Extrasynaptic vesicular transmitter release from the somata of substantia nigra neurons in rat midbrain slices. J. Neurosci. 18:1998;3548-3553.
99. Jahr C.E., Nicoll R.A. Dendrodendritic inhibition: demonstration with intracellular recording. Science. 207:1980;1473-1475.
100. Johnston D., Hoffman D.A., Colbert C.M., Magee J.C. Regulation of back-propagating action potentials in hippocampal neurons. Curr. Opin. Neurobiol. 9:1999;288-292.
101. Kafitz K.W., Rose C.R., Thoenen H., Konnerth A. Neurotrophin-evoked rapid excitation through TrkB receptors. Nature. 401:1999;918-921.
102. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19:1999;4544-4558.
103. Katona I., Rancz E.A., Acsady L., Ledent C., Mackie K., Hajos N., Freund T.F. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci. 21:2001;9506-9518.
104. Kim J., Alger B.E. Random response fluctuations lead to spurious paired-pulse facilitation. J. Neurosci. 21:2001;9608-9618.
105. Kim H.G., Wang T., Olafsson P., Lu B. Neurotrophin 3 potentiates neuronal activity and inhibits γ-aminobutyratergic synaptic transmission in cortical neurons. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12341-12345.
106. Kim, J., Isokawa, M., Ledent, C., Alger, B.E., 2002. Activation of muscarinic acetylcholine receptors enhances the release of endocannabinoids in the hippocampus. J. Neurosci., in press.
107. Kirischuk S., Clements J.D., Grantyn R. Presynaptic and postsynaptic mechanisms underlie paired pulse depression at single GABAergic boutons in rat collicular cultures. J. Physiol. 543:2002;99-116.
108. Kiss J.P., Vizi E.S. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci. 24:2001;211-215.
109. 2+ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro. Br. J. Pharmacol. 105:1992;470-474.
110. Kohara K., Kitamura A., Morishima M., Tsumoto T. Activity-dependent transfer of brain-derived neurotrophic factor to postsynaptic neurons. Science. 291:2001;2419-2423.
111. Kombian S.B., Mouginot D., Pittman Q.J. Dendritically released peptides act as retrograde modulators of afferent excitation in the supraoptic nucleus in vitro. Neuron. 19:1997;903-912.
112. Kornecki E., Wieraszko A., Chan J., Ehrlich Y.H. Platelet activating factor (PAF) in memory formation: role as a retrograde messenger in long-term potentiation. J. Lipid Mediat. Cell Signal. 14:1996;115-126.
113. Kovalchuk Y., Hanse E., Kafitz K.W., Konnerth A. Postsynaptic induction of BDNF-mediated long-term potentiation. Science. 295:2002;1729-1734.
114. Kraushaar U., Jonas P. Efficacy and stability of quantal GABA release at a hippocampal interneuron-principal neuron synapse. J. Neurosci. 20:2000;5594-5607.
115. Kreitzer A.C., Regehr W.G. Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J. Neurosci. 21(RC174):2001a;1-5.
116. Kreitzer A.C., Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron. 29:2001b;717-727.
117. Kreitzer A.C., Carter A.G., Regehr W.G. Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron. 34:2002;787-796.
118. Kuhn, T., 1970. The structure of scientific revolutions. In: Neurath, O. (Ed.), The International Encyclopedia of Applied Science. University of Chicago Press, Chicago.
119. Kullmann D.M., Asztely F. Extrasynaptic glutamate spillover in the hippocampus: evidence and implications. Trends Neurosci. 21:1998;8-14.
120. Kullmann D.M., Min M.-Y., Asztely F., Rusakov D.A. Extracellular glutamate diffusion determines the occupancy of glutamate receptors at CA1 synapses in the hippocampus. Philos. Trans. R. Soc. London B. 354:1999;395-402.
121. Lambert N.A., Teyler T.J. Adenosine depresses excitatory but not fast inhibitory synaptic transmission in area CA1 of the rat hippocampus. Neurosci. Lett. 122:1991;50-52.
122. Latini S., Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 79:2001;463-484.
123. A receptor-mediated IPSPs after epileptiform burst discharges in CA1 pyramidal cells. J. Neurophysiol. 79:1998;659-669.
124. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., Bohme G.A., Imperato A., Pedrazzini T., Roques B.P., Vassart G., Fratta W., Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 283:1999;401-404.
125. Lenz R.A., Alger B.E. Calcium dependence of depolarization-induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons. J. Physiol. (London). 521:1999;147-157.
126. Lenz R.A., Wagner J.J., Alger B.E. N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. J. Physiol. (London). 512:1998;61-73.
127. Levenes C., Daniel H., Soubrie P., Crepel F. Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J. Physiol. (London). 510:1998;867-879.
128. Levenes C., Daniel H., Crepel F. Retrograde modulation of transmitter release by postsynaptic subtype 1 metabotropic glutamate receptors in the rat cerebellum. J. Physiol. (London). 537:2001;125-140.
129. Llano I., Marty A. Presynaptic metabotropic glutamatergic regulation of inhibitory synapses in rat cerebellar slices. J. Physiol. (London). 486:1995;163-176.
130. Llano I., Leresche N., Marty A. Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron. 6:1991;565-574.
131. Llinas, R., 1975. Electroresponsive properties of dendrites in central neurons. In: Kreutzberg, G.W. (Ed.), Advances in Neurology, vol. 12. Raven, New York, pp. 1-13.
132. Ludwig M. Dendritic release of vasopressin and oxytocin. J. Neuroendocrinol. 10:1998;881-895.
133. Lujan R., Nusser Z., Roberts J.D.B., Shigemoto R., Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci. 8:1996;1488-1500.
134. Luscher C., Nicoll R.A., Malenka R.C., Muller D. Synaptic plasticity and dynamic modulation of the postsynaptic membrane. Nat. Neurosci. 3:2000;545-550.
135. MacDermott A.B., Role L.W., Siegelbaum S.A. Presynaptic ionotropic receptors and the control of transmitter release. Ann. Rev. Neurosci. 22:1999;443-485.
136. A receptor channels. Ann. Rev. Neurosci. 17:1994;569-602.
137. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3825-3829.
138. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15:1995;6552-6561.
139. Maejima T., Hasimoto K., Yoshida T., Aiba A., Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron. 31:2001;463-475.
140. Magee, J.C., 1999. Voltage-gated ion channels in dendrites. In: Stuart, G., Spruston, N., Hausser, M. (Eds.), Dendrites. Oxford University Press, Oxford, pp. 139-160.
141. Malenka R.C., Nicoll R.A. Long-term potentiation - a decade of progress? Science. 285:1999;1870-1874.
142. Maletic-Savatic M., Malinow R. Calcium-evoked dendritic exocytosis in cultured hippocampal neurons. Part I. Trans-Golgi network-derived organelles undergo regulated exocytosis. J. Neurosci. 18:1998;6803-6813.
143. Maletic-Savatic M., Koothan T., Malinow R. Calcium-evoked dendritic exocytosis in cultured hippocampal neurons. Part II. Mediation by calcium/calmodulin-dependent protein kinase II. J. Neurosci. 18:1998;6814-6821.
144. Mannaioni G., Marino M.J., Valenti O., Traynelis S.F., Conn P.J. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J. Neurosci. 21:2001;5925-5934.
145. Manzoni O.J., Manabe T., Nicoll R.A. Release of adenosine by activation of NMDA receptors in the hippocampus. Science. 265:1994;2098-2101.
146. Marino M.J., Wittmann M., Bradley S.R., Hubert G.W., Smith Y., Conn P.J. Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata. J. Neurosci. 21:2001;7001-7012.
147. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgänsberger W., Di Marzo V., Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 418:2002;530-534.
148. Martin L.A., Alger B.E. Muscarinic facilitation of the occurrence of depolarization-induced suppression of inhibition in rat hippocampus. Neuroscience. 92:1999;61-71.
149. Martin B.R., Mechoulam R., Razdan R.K. Discovery and characterization of endogenous cannabinoids. Life Sci. 65:1999;573-595.
150. A receptor-mediated IPSCs to depolarization-induced suppression of inhibition in rat hippocampus. J. Physiol. (London). 532:2001;685-700.
151. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
152. McAllister S.D., Griffin G., Satin L.S., Abood M.E. Cannabinoid receptors can activate and inhibit G-protein-coupled inwardly rectifying potassium channels in a Xenopus oocyte expression system. J. Pharmacol. Exp. Ther. 291:1999;618-626.
153. Mechoulam R., Ben Shabat S., Hanus L., Fride E., Vogel Z., Bayewitch M., Sulcova A.E. Endogenous cannabinoid ligands - chemical and biological studies. J. Lipid Mediat. Cell Signal. 14:1996;45-49.
154. Miledi R. Strontium as a substitute for calcium in the process of transmitter release at the neuromuscular junction. Nature. 5067:1966;1233-1234.
155. Miller F.D., Kaplan D.R. On Trk for retrograde signaling. Neuron. 32:2001;767-770.
156. Mitchell S.J., Silver R.A. Glutamate spillover suppresses inhibition by activating presynaptic mGluRs. Nature. 404:2000;498-502.
157. Mitchell J.B., Lupica C.R., Dunwiddie T.V. Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J. Neurosci. 13:1993;3439-3447.
158. 2+ channels to reduce GABA release onto rat striatal cholinergic interneurons. J. Physiol. (London). 533:2001;479-492.
159. 2+ supports depolarization-induced suppression of inhibition and provides new evidence for a presynaptic expression mechanism in rat hippocampal slices. J. Physiol. (London). 505:1997;307-317.
160. Aergic IPSCs in hippocampal CA1 neurons in vitro. Soc. Neurosci. Abstr. 24:1998;843.
161. Aergic transmission in hippocampal CA1. J. Neurophysiol. 82:1999;2556-2564.
162. Morishita W., Alger B.E. Differential effects of the group II mGluR agonist, DCG-IV, on depolarization-induced suppression of inhibition in hippocampal CA1 and CA3 neurons. Hippocampus. 10:2000;261-268.
163. Morishita W., Alger B.E. Direct depolarization and antidromic action potentials transiently suppress dendritic IPSPs in hippocampal CA1 pyramidal cells. J. Neurophysiol. 85:2001;480-484.
164. Morishita W., Kirov S.A., Pitler T.A., Martin L.A., Lenz R.A., Alger B.E. N-Ethylmaleimide blocks depolarization-induced suppression of inhibition and enhances GABA release in the rat hippocampal slice in vitro. J. Neurosci. 17:1997;941-950.
165. Morishita W., Kirov S.A., Alger B.E. Evidence for metabotropic glutamate receptor activation in the induction of depolarization-induced suppression of inhibition in hippocampal CA1. J. Neurosci. 18:1998;4870-4882.
166. Morisset V., Urban L. Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord. J. Neurophysiol. 86:2001;40-48.
167. Nakanishi S. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron. 13:1994;1031-1037.
168. 2+ microdomains: new tools for understanding their roles in neurotransmitter release. Neuron. 20:1998;389-399.
169. Nicoll R.A., Alger B.E. Presynaptic inhibition: transmitter and ionic mechanisms. Int. Rev. Neurobiol. 21:1979;217-258.
170. O'Dell T.J., Hawkins R.D., Kandel E.R., Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. U.S.A. 88:1991;11285-11289.
171. Ohno-Shosaku T., Yamamoto C. Effects of metabotropic glutamate receptor agonists on excitatory and inhibitory transmissions in cultured rat hippocampal neurons. Brain Res. 705:1995;337-340.
172. Aergic transmission in rat cultured hippocampal neurons. Neurosci. Lett. 181:1994;145-148.
173. Ohno-Shosaku T., Sawada S., Yamamoto C. Properties of depolarization-induced suppression of inhibitory transmission in cultured rat hippocampal neurons. Pflugers Arch. 435:1998;273-279.
174. Ohno-Shosaku T., Sawada S., Kano M. Heterosynaptic expression of depolarization-induced suppression of inhibition (DSI) in rat hippocampal cultures. Neurosci. Res. 36:2000;67-71.
175. Ohno-Shosaku T., Maejima T., Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron. 29:2001;729-738.
176. Ohno-Shosaku T., Tsubokawa H., Mizushima I., Yoneda N., Zimmer A., Kano M. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J. Neurosci. 22:2002;3864-3872.
177. Onaivi E.S., Leonard C.M., Ishiguro H., Zhang P.W., Lin Z., Akinshola B.E., Uhl G.R. Endocannabinoids and cannabinoid receptor genetics. Prog. Neurobiol. 66:2002;307-344.
178. Pacelli G.J., Kelso S.R. Trans-ACPD reduces multiple components of synaptic transmission in the rat hippocampus. Neurosci. Lett. 132:1991;267-269.
179. 2+ channels in a neuronal expression system. Mol. Pharmacol. 49:1996;707-714.
180. Pertwee R.G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74:1997;129-180.
181. Pin J.-P., De Colle C., Bessis A.-S., Acher F. New perspectives for the development of selective metabotropic glutamate receptor ligands. Eur. J. Pharmacol. 375:1999;277-294.
182. Piomelli D., Greengard P. Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling. Trends Pharmacol. Sci. 11:1990;367-373.
183. Pitler T.A., Alger B.E. Elevation of intracellular Ca inhibits GABAergic IPSPs in hippocampal neurons. Soc. Neurosci. Abstr. 16:1990;467.
184. A responses in hippocampal pyramidal cells. J. Neurosci. 12:1992;4122-4132.
185. Pitler T.A., Alger B.E. Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G-protein involvement in a presynaptic mechanism. Neuron. 13:1994;1447-1455.
186. Poncer J.-C., Miles R. Fast and slow excitation of inhibitory cells in the CA3 region of the hippocampus. J. Neurobiol. 26:1995;386-395.
187. Poncer J.-C., Shinozaki H., Miles R. Dual modulation of synaptic inhibition by distinct metabotropic glutamate receptors in the rat hippocampus. J. Physiol. (London). 485:1995;121-134.
188. Poncer J.-C., McKinney R.A., Gahwiler B.H., Thompson S.M. Either N- or P-type calcium channels mediate GABA release at distinct hippocampal inhibitory synapses. Neuron. 18:1997;463-472.
189. Poss K.D., Thomas M.J., Ebralidze A.K., O'Dell T.J., Tonegawa S. Hippocampal long-term potentiation is normal in heme oxygenase-2 mutant mice. Neuron. 15:1995;867-873.
190. Pucak M.L., Grace A.A. Regulation of substantia nigra dopamine neurons. Crit. Rev. Neurobiol. 9:1994;67-89.
191. Puopolo M., Hochstetler S.E., Gustincich S., Wightman R.M., Raviola E. Extrasynaptic release of dopamine in a retinal neuron: activity dependence and transmitter modulation. Neuron. 30:2001;211-225.
192. Raggenbass M. Vasopressin- and oxytocin-induced activity in the central nervous system: electrophysiological studies using in vitro systems. Prog. Neurobiol. 64:2001;307-326.
193. Ramon y Cajal, S., 1995. Histology of the Nervous System of Man and Vertebrates: General Principles, Spinal Cord, Spinal Ganglia, Medulla and Pons, vol. 1. Oxford University Press, New York.
194. Regehr W.G., Tank D.W. Calcium concentration dynamics produced by synaptic activation of CA1 hippocampal pyramidal cells. J. Neurosci. 12:1992;4202-4223.
195. Reibaud M., Obinu M.C., Ledent C., Parmentier M., Bohme G.A., Imperato A. Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur. J. Pharmacol. 379:1999;R1-R2.
196. Robbe D., Alonso G., Duchamp F., Bockaert J., Manzoni O.J. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21:2001;109-116.
197. Robbe D., Kopf M., Remaury A., Bockaert J., Manzoni O.J. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. U.S.A. 99:2002;8384-8388.
198. Robitaille R. Modulation of synaptic efficacy and synaptic depression by glial cells at the frog neuromuscular junction. Neuron. 21:1998;847-855.
199. Rodriguez J.J., Mackie K., Pickel V.M. Ultrastructural localization of the CB1 cannabinoid receptor in μ-opioid receptor patches of the rat caudate putamen nucleus. J. Neurosci. 21:2001;823-833.
200. Romano C., Sesma M.A., McDonald C.T., O'Malley K., van den Pol A.N., Olney J.W. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J. Comp. Neurol. 355:1995;455-469.
201. Schoppa N.E., Kinzie J.M., Sahara Y., Segerson T.P., Westbrook G.L. Dendrodendritic inhibition in the olfactory bulb is driven by NMDA receptors. J. Neurosci. 18:1998;6790-6802.
202. Schoepp D.D., Jane D.E., Monn J.A. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology. 38:1999;1431-1476.
203. Schuman E.M., Madison D.V. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science. 254:1991;1503-1506.
204. + M-current in hippocampal CA1 neurons. J. Neurosci. 20:2000;51-58.
205. Seeburg P.H. Neurodegeneration. A silent channel opens its gates. Nature. 388:1997;716-717.
206. Shen M., Piser T.M., Seybold V.S., Thayer S.A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16:1996;4322-4334.
207. Simmons M.L., Terman G.W., Gibbs S.M., Chavkin C. L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells. Neuron. 14:1995;1265-1272.
208. Smit A.B., Syed N.I., Schaap D., van Minnen J., Klumperman J., Kits K.S., Lodder H., van der Schors R.C., van Elk R., Sorgedrager B., Brejc K., Sixma T.K., Geraerts W.P.M. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature. 411:2001;261-268.
209. Snyder S.H. Nitric oxide. More jobs for that molecule. Nature. 372:1994;504-505.
210. Snyder S.H., Jaffrey S.R., Zakhary R. Nitric oxide and carbon monoxide: parallel roles as neural messengers. Brain Res. Rev. 26:1998;167-175.
211. Son H., Lu Y.F., Zhuo M., Arancio O., Kandel E.R., Hawkins R.D. The specific role of cGMP in hippocampal LTP, Learning. Learn. Mem. 5:1998;231-245.
212. Spacek J., Harris K.M. Three-dimensional organization of smooth endoplasmic reticulum in hippocampal CA1 dendrites and dendritic spines of the immature and mature rat. J. Neurosci. 17:1997;190-203.
213. Spruston, N., Stuart, G., Hausser, M., 1999. Dendritic integration. In: Stuart, G., Spruston, N., Hausser, M. (Eds.), Dendrites. Oxford University Press, Oxford, pp. 231-270.
214. Stella N., Piomelli D. Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur. J. Pharmacol. 425:2001;189-196.
215. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature. 388:1997;773-778.
216. A receptor function in hippocampal cells is maintained by phosphorylation factors. Science. 241:1988;339-341.
217. Stuart G., Spruston N., Sakmann B., Hausser M. Action potential initiation and backpropagation in neurons of the mammalian CNS. Trends Neurosci. 20:1997;125-131.
218. Sullivan J.M. Mechanisms of cannabinoid receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J. Neurophysiol. 82:1999;1286-1294.
219. Sung K.-W., Choi S., Lovinger D.M. Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. J. Neurophysiol. 86:2001;2405-2412.
220. Szabo B., Dorner L., Pfreundtner C., Norenberg W., Starke K. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience. 85:1998;395-403.
221. Szabo B., Wallmichrath I., Mathonia P., Pfreundtner C. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata. Neuroscience. 97:2000;89-97.
222. Takahashi K.A., Linden D.J. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. J. Neurophysiol. 83:2000;1167-1180.
223. A synaptic responses by brain-derived neurotrophic factor (BDNF) in rat hippocampus. J. Neurosci. 17:1997;2959-2966.
224. Tang K.-C., Lovinger D.M. Role of pertussis toxin-sensitive G-proteins in synaptic transmission and plasticity at corticostriatal synapses. J. Neurophysiol. 83:2000;60-69.
225. Tasker J.G., Dudek F.E. Electrophysiology of GABA-mediated synaptic transmission and possible roles in epilepsy. Neurochem. Res. 16:1991;251-262.
226. Thompson S.M. Modulation of inhibitory synaptic transmission in the hippocampus. Prog. Neurobiol. 42:1994;575-609.
227. Thompson S.M., Haas H.L., Gahwiler B.H. Comparison of the actions of adenosine at pre- and postsynaptic receptors in the rat hippocampus in vitro. J. Physiol. (London). 451:1992;347-363.
228. Thomson A.M. Facilitation, augmentation and potentiation at central synapses. Trends Neurosci. 23:2000;305-312.
229. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. 83:1998;393-411.
230. Tsou K., Mackie K., Sanudo-Pena M.C., Walker J.M. Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience. 93:1999;969-975.
231. Twitchell W., Brown S., Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78:1997;43-50.
232. Tyler W.J., Pozzo-Miller L.D. BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. J. Neurosci. 21:2001;4249-4258.
233. Varma N., Carlson G.C., Ledent C., Alger B.E. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J. Neurosci. 21(RC188):2001;1-5.
234. Varma N., Brager D.H., Morishita W., Lenz R.A., London B., Alger B.E. Presynaptic mechanisms of DSI expression in hippocampus. Neuropharmacology. 43:2002;550-562.
235. Vaughan C.W., McGregor I.S., Christie M.J. Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro. Br. J. Pharmacol. 127:1999;935-940.
236. Vaughan C.W., Connor M., Bagley E.E., Christie M.J. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol. Pharmacol. 57:2000;288-295.
237. Vincent P., Marty A. Neighboring cerebellar Purkinje cells communicate via retrograde inhibition of common presynaptic interneurons. Neuron. 11:1993;885-893.
238. Vincent P., Marty A. Fluctuations of inhibitory postsynaptic currents in Purkinje cells from rat cerebellar slices. J. Physiol. (London). 494:1996;183-199.
239. Vincent P., Armstrong C.M., Marty A. Inhibitory synaptic currents in rat cerebellar Purkinje cells: modulation by postsynaptic depolarization. J. Physiol. (London). 456:1992;453-471.
240. Vizi E.S., Kiss J.P. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus. 8:1998;566-607.
241. Volgushev M., Balaban P., Chistiakova M., Eysel U.T. Retrograde signalling with nitric oxide at neocortical synapses. Eur. J. Neurosci. 12:2000;4255-4267.
242. Wagner J.J., Alger B.E. Increased neuronal excitability during depolarization-induced suppression of inhibition in rat hippocampus. J. Physiol. (London). 495:1996;107-112.
243. Wagner, J.J., Chavkin, C.I., 1995. Neuropharmacology of endogenous opioid peptides. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven, New York, pp. 519-529.
244. Wagner J.J., Evans C.J., Chavkin C. Focal stimulation of the mossy fibers releases endogenous dynorphins that bind κ1-opioid receptors in guinea pig hippocampus. J. Neurochem. 57:1991;333-343.
245. Wagner J.J., Caudle R.M., Chavkin C. κ-Opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus. J. Neurosci. 12:1992;132-141.
246. Wagner J.J., Terman G.W., Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature. 363:1993;451-454.
247. Waldeck R.F., Pereda A., Faber D.S. Properties and plasticity of paired-pulse depression at a central synapse. J. Neurosci. 20:2000;5312-5320.
248. Wallmichrath I., Szabo B. Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata. Naunyn-Schmiedeberg's Arch. Pharmacol. 365:2002;326-334.
249. Wang J., Zucker R.S. Photolysis-induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons. J. Physiol. (London). 533:2001;757-763.
250. Weisskopf M.G., Zalutsky R.A., Nicoll R.A. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature. 362:1993;423-427.
251. Westlake T.M., Howlett A.C., Bonner T.I., Matsuda L.A., Herkenham M. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience. 63:1994;637-652.
252. Wigstrom H., Gustafsson B. Facilitation of hippocampal long-lasting potentiation by GABA antagonists. Acta Physiol. Scand. 125:1985;159-172.
253. Williams J.H. Retrograde messengers and long-term potentiation: a progress report. J. Lipid Mediat. Cell Signal. 14:1996;331-339.
254. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature. 410:2001;588-592.
255. Wilson R.I., Nicoll R.A. Endocannabinoid signaling in the brain. Science. 296:2002;678-682.
256. Wilson R.I., Kunos G., Nicoll R.A. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron. 31:2001;453-462.
257. Wong R.K.S., Prince D.A., Basbaum A.I. Intradendritic recordings from hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 76:1979;986-990.
258. Wu S.Y., Dun N.J. Potentiation of IPSCs by nitric oxide in immature rat sympathetic pre-ganglionic neurons in vitro. J. Physiol. (London). 495:1996;479-490.
259. Xu B., Gottschalk W., Chow A., Wilson R.I., Schnell E., Zang K., Wang D., Nicoll R.A., Lu B., Reichardt L.F. The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J. Neurosci. 20:2000;6888-6897.
260. Yoshida T., Hashimoto K., Zimmer A., Maejima T., Araishi K., Kano M. The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J. Neurosci. 22:2002;1690-1697.
261. Yung W.-H., Leung P.-S., Ng S.S.M., Zhang J., Chan S.C.Y., Chow B.K.C. Secretin facilitates GABA transmission in the cerebellum. J. Neurosci. 21:2001;7063-7068.
262. Yuste R., Tank D.W. Dendritic integration in mammalian neurons, a century after Cajal. Neuron. 16:1996;701-716.
263. Zhuo M., Small S.A., Kandel E.R., Hawkins R.D. Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. Science. 260:1993;1946-1950.
264. Zhuo M., Hu Y., Schultz C., Kandel E.R., Hawkins R.D. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature. 368:1994;635-639.
265. Zilberter Y. Dendritic release of glutamate suppresses synaptic inhibition of pyramidal neurons in rat neocortex. J. Physiol. (London). 528:2000;489-496.
266. Zilberter Y., Kaiser K.M.M., Sakmann B. Dendritic GABA release depresses excitatory transmission between layer 2/3 pyramidal and bitufted neurons in rat neocortex. Neuron. 24:1999;979-988.
267. Zoli M., Jansson A., Sykova E., Agnati L.F., Fuxe K. Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol. Sci. 20:1999;142-150.
268. Zucker R.S. Short-term synaptic plasticity. Ann. Rev. Neurosci. 12:1989;13-31.